Insider Transactions last 24 months for Evoke Pharma, Inc.  -  NSDQ: EVOK

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
D'Onofrio Matthew JChief Executive Officer03/21/2025AADirectCOM1,000$2.80$2,797.209,820
Kowieski MarkChief Financial Officer03/20/2025AADirectCOM4,500$3.21$14,463.004,916
D'Onofrio Matthew JChief Executive Officer02/28/2025AADirectCOM6,849$3.65$24,998.858,820
Nantahala Capital Management, LlcOther01/28/2025DSIndirectCOM41$4.39$179.87148,153
1   You are at page 1 of 1 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel